🇺🇸 FDA
Patent

US 9327031

Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

granted A61KA61K31/5575A61K47/02

Quick answer

US patent 9327031 (Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same) held by United Therapeutics Corporation expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Therapeutics Corporation
Grant date
Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/5575, A61K47/02, A61K47/18, A61K47/183